VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, December 31, 2025

Stock Comparison

Berkshire Hathaway Inc. vs Johnson & Johnson

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Berkshire Hathaway Inc.

BRK.B · New York Stock Exchange

Market cap (USD)
SectorFinancials
CountryUS
Data as of2025-12-30
Moat score
64/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Berkshire Hathaway Inc.'s moat claims, evidence, and risks.

View BRK.B analysis

Johnson & Johnson

JNJ · New York Stock Exchange

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-21
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.

View JNJ analysis

Comparison highlights

  • Moat score gap: Berkshire Hathaway Inc. leads (64 / 100 vs 61 / 100 for Johnson & Johnson).
  • Segment focus: Berkshire Hathaway Inc. has 11 segments (28.3% in Insurance (underwriting + investment income)); Johnson & Johnson has 2 segments (64.1% in Innovative Medicine).
  • Primary market structure: Competitive vs Competitive. Pricing power: n/a vs Moderate.
  • Moat breadth: Berkshire Hathaway Inc. has 17 moat types across 4 domains; Johnson & Johnson has 5 across 3.

Primary market context

Berkshire Hathaway Inc.

Insurance (underwriting + investment income)

Market

Insurance and reinsurance (property and casualty + life/health), including float-funded investing

Geography

Global

Customer

Consumers and businesses (policyholders) and insurers (reinsurance cedents)

Role

Underwriter and reinsurer plus investment manager of float

Revenue share

28.3%

Johnson & Johnson

Innovative Medicine

Market

Branded prescription pharmaceuticals (biopharma)

Geography

Global

Customer

Wholesalers, hospitals, retailers, healthcare professionals, payers

Role

Drug discovery, development, manufacturing, commercialization

Revenue share

64.1%

Side-by-side metrics

Berkshire Hathaway Inc.
Johnson & Johnson
Ticker / Exchange
BRK.B - New York Stock Exchange
JNJ - New York Stock Exchange
Market cap (USD)
n/a
n/a
Sector
Financials
Healthcare
HQ country
US
US
Primary segment
Insurance (underwriting + investment income)
Innovative Medicine
Market structure
Competitive
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
n/a
Moderate
Moat score
64 / 100
61 / 100
Moat domains
Financial, Supply, Demand, Legal
Legal, Demand, Supply
Last update
2025-12-30
2025-12-21

Moat coverage

Shared moat types

Brand TrustIP Choke PointTraining Org Change CostsService Field Network

Berkshire Hathaway Inc. strengths

Float PrepaymentCapacity MoatPhysical Network DensityLong Term ContractsConcession LicensePermits Rights Of WayDesign In QualificationCapex Knowhow ScaleScale Economies Unit CostDistribution ControlPreferential Input AccessScope EconomiesCost Of Capital Advantage

Johnson & Johnson strengths

Regulated Standards Pipe

Segment mix

Berkshire Hathaway Inc. segments

Full profile >

Insurance (underwriting + investment income)

Competitive

28.3%

BNSF Railway (freight rail transportation)

Oligopoly

6.4%

Berkshire Hathaway Energy (regulated utilities, pipelines, renewables)

Monopoly

7.1%

Industrial products manufacturing (PCC, Lubrizol, IMC, Marmon, etc.)

Oligopoly

9.7%

Building products & housing (Clayton Homes, Shaw, Johns Manville, Benjamin Moore, etc.)

Competitive

7.2%

Consumer products manufacturing (Duracell, Forest River, apparel/footwear, toys, etc.)

Competitive

4%

Service businesses (FlightSafety, NetJets, TTI, Dairy Queen, etc.)

Competitive

5.6%

Retailing businesses (Berkshire Hathaway Automotive, home furnishings, jewelry, See's, etc.)

Competitive

5.2%

Pilot Travel Centers (travel centers + wholesale fuel marketing)

Oligopoly

12.6%

McLane (wholesale distribution to convenience stores and restaurants)

Oligopoly

14%

Holding company capital allocation and investing

Competitive

n/a

Johnson & Johnson segments

Full profile >

Innovative Medicine

Competitive

64.1%

MedTech

Oligopoly

35.9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.